Evinacumab for Homozygous Familial Hypercholesterolemia

N Engl J Med. 2021 Feb 11;384(6):e17. doi: 10.1056/NEJMc2033612.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Homozygote
  • Humans
  • Hyperlipoproteinemia Type II* / drug therapy
  • Hyperlipoproteinemia Type II* / genetics

Substances

  • Antibodies, Monoclonal
  • evinacumab